Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rite Aid Corp (RAD)

Rite Aid Corp (RAD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 826,122
  • Shares Outstanding, K 54,819
  • Annual Sales, $ 21,640 M
  • Annual Income, $ -422,210 K
  • 60-Month Beta 1.52
  • Price/Sales 0.04
  • Price/Cash Flow 1.04
  • Price/Book 0.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/20
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.20
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +35.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.24 +63.10%
on 03/13/20
19.93 -24.39%
on 03/19/20
+1.56 (+11.55%)
since 02/27/20
3-Month
9.24 +63.10%
on 03/13/20
19.93 -24.39%
on 03/19/20
-5.23 (-25.76%)
since 12/27/19
52-Week
5.04 +199.01%
on 08/27/19
23.88 -36.89%
on 12/27/19
+2.21 (+17.22%)
since 03/27/19

Most Recent Stories

More News
Rite Aid Joins White House COVID-19 Response Working Group

Today, Rite Aid (NYSE: RAD) announced it has joined the White House COVID-19 Response Working Group. Rite Aid's mission is to keep the communities it serves healthy and beginning Monday, March 23, the...

RAD : 15.07 (+6.80%)
Has Rite Aid (RAD) Outpaced Other Retail-Wholesale Stocks This Year?

Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?

RAD : 15.07 (+6.80%)
Do Options Traders Know Something About Rite Aid (RAD) Stock We Don't?

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

RAD : 15.07 (+6.80%)
Walgreens Boots Alliance (WBA) in Focus: Stock Moves 6.5% Higher

Walgreens Boots Alliance (WBA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

RAD : 15.07 (+6.80%)
WBA : 44.00 (-3.66%)
Rite Aid Joins Fight Against COVID-19 by Expanding Services

In the wake of the COVID-19 crisis, Rite Aid (RAD) is gearing up to serve customers better by providing home delivery and pick-up services.

TGT : 94.74 (-1.38%)
RAD : 15.07 (+6.80%)
DG : 146.12 (+3.99%)
WBA : 44.00 (-3.66%)
More Efficiency, Service and Value on the Horizon as EnvisionRxOptions Integrates Its Family of Brands as Elixir

EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, announced it will further integrate its pharmacy benefits, services and technology companies, rebranding under the new name, Elixir....

RAD : 15.07 (+6.80%)
New Strong Buy Stocks for March 18th

New Strong Buy Stocks for March 18th

RAD : 15.07 (+6.80%)
BBX : 1.6900 (-12.89%)
AZUL : 11.44 (-7.22%)
ASX : 3.58 (-9.82%)
AMX : 12.18 (-6.60%)
Rite Aid Expands Services in Response to COVID-19

Today, Rite Aid (NYSE: RAD) announced it has taken several steps to support its employees, customers and the local communities the company serves during the global coronavirus (COVID-19) pandemic.

RAD : 15.07 (+6.80%)
Business Capital Delivers $8M Financing for Pharmaceutical Company

Business Capital structured and delivered an $8M secured asset based credit facility for Nivagen Pharmaceuticals, a specialty company that develops and sells generic prescription drugs for the North American...

RAD : 15.07 (+6.80%)
Thinking about buying stock in Chewy, General Electric, GrubHub, Inovio Pharmaceuticals, or Rite Aid?

InvestorsObserver issues critical PriceWatch Alerts for CHWY, GE, GRUB, INO, and RAD.

GE : 7.62 (-6.16%)
GRUB : 39.16 (+2.62%)
INO : 8.32 (+16.36%)
RAD : 15.07 (+6.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade RAD with:

Business Summary

Rite Aid Corporation is a retail drugstore chain in the United States serving customers in numerous states across the country and in the District of Columbia. It operates stores in the majority of the major U.S. metropolitan markets. The company operates in two business segments: the retail drug segment...

See More

Key Turning Points

2nd Resistance Point 16.90
1st Resistance Point 15.98
Last Price 15.07
1st Support Level 13.92
2nd Support Level 12.78

See More

52-Week High 23.88
Fibonacci 61.8% 16.68
Last Price 15.07
Fibonacci 50% 14.46
Fibonacci 38.2% 12.24
52-Week Low 5.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar